NLRP3 inflammasome: The rising star in cardiovascular diseases

Yidan Zheng1, Li Xu1, Nianguo Dong1

  • 1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

The nucleotide oligomerization domain-, leucine-rich repeat-, and pyrin domain-containing protein 3 (NLRP3) inflammasome drives cardiovascular disease progression and inflammation. Targeting NLRP3 inflammasome offers potential therapeutic strategies for these prevalent global diseases.

Area of Science:

  • Cardiovascular Diseases
  • Innate Immunity
  • Inflammasome Biology

Background:

  • Cardiovascular diseases (CVDs) are the leading global cause of mortality.
  • Inflammasome activation, particularly NLRP3 inflammasome, is implicated in CVD pathogenesis.
  • NLRP3 inflammasome mediates inflammatory responses and programmed cell death (pyroptosis).

Purpose of the Study:

  • To review the role of NLRP3 inflammasome in various cardiovascular diseases.
  • To discuss the mechanisms by which NLRP3 inflammasome contributes to CVD.
  • To explore potential therapeutic interventions targeting the NLRP3 inflammasome pathway.

Main Methods:

  • Literature review synthesizing current research on NLRP3 inflammasome in CVD.
  • Analysis of studies detailing NLRP3 inflammasome activation and downstream effects.
  • Discussion of therapeutic strategies targeting NLRP3 inflammasome components or activity.

Main Results:

  • NLRP3 inflammasome activation is a key driver in atherosclerosis, myocardial infarction, heart failure, and other CVDs.
  • NLRP3 inflammasome promotes inflammation through IL-1 family cytokine release and pyroptosis.
  • Evidence supports NLRP3 inflammasome's significant role in the inflammatory cascade of cardiovascular pathologies.

Conclusions:

  • The NLRP3 inflammasome is a critical mediator of inflammation and cell death in cardiovascular diseases.
  • Understanding NLRP3 inflammasome function provides insights into CVD pathogenesis.
  • Targeting the NLRP3 inflammasome presents a promising therapeutic avenue for managing cardiovascular diseases.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
54.6K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
189
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31